Moreover, when comparing DLBCL to control samples, discordant results were seen for PAX5 (GCB p=0.98, non-GCB p=0.043) and BCL2 (GCB p=0.61, non-GCB p=0.021) compared to the findings in the FFPE samples. This evidence concerns the gene PAX5 and diffuse large B-cell lymphoma.